6.97
price up icon4.34%   0.29
after-market After Hours: 7.30 0.33 +4.73%
loading

Neuropace Inc Stock (NPCE) Forecast

The Neuropace Inc (NPCE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.6733, representing a -61.65% decrease from the current price of $6.97. The highest analyst price target is $4.704, and the lowest is $0.6426.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NPCE Price Target
Average 2.3569 (-66.19% Downside)
loading

Is Neuropace Inc (NPCE) A Buy Now?

Oscillators
Name Value Action
RSI(14) 46.88 Neutral
STOCH(9,6) 35.97 Neutral
STOCHRSI(14) 48.79 Neutral
MACD(12,26) -0.1312 Sell
ADX(14) 16.53 Neutral
William %R -56.74 Neutral
CCI(14) -78.59 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
7.002
Sell
6.9726
Sell
MA20
7.0905
Sell
7.0886
Sell
MA50
7.3081
Sell
7.3274
Sell
MA100
7.3273
Sell
8.0192
Sell
MA200
10.43
Sell
8.3365
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, NPCE could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on NPCE, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 46.88 indicates that NPCE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 35.97 indicates that NPCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 48.79 indicates that NPCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 16.53 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -78.59 indicates that NPCE is still oversold but not to an extreme extent.

Long-term NPCE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Neuropace Inc financial reports and earnings history, Neuropace Inc (NPCE) stock could reach $3.0441 by 2030, $16.18 by 2040 and $47.27 by 2050. See the projected annual prices until 2050 of the Neuropace Inc stock below:

  • Neuropace Inc (NPCE) is expected to reach an average price of $19.08 in 2035, with a high prediction of $19.00 and a low estimate of $18.81. This indicates an $173.68% rise from the last recorded price of $6.97.
  • Neuropace Inc (NPCE) stock is projected to chart a bullish course in 2040, with an average price target of $18.93, representing an $171.59% surge from its current level. The forecast ranges from a conservative $9.5641 to a sky-high $16.18.
  • Our analysts predict Neuropace Inc (NPCE) to jump 377.14% by 2045, soaring from $33.86 to an average price of $33.26, potentially reaching $33.26. While $33.86 is the low estimate, the potential upside is significant.
  • Neuropace Inc (NPCE) stock is expected to climb by 2050, reaching an average of $47.69, a $584.24% jump from its current level. However, a wide range of estimates exists, with high and low targets of $47.27 and $47.99, respectively, highlighting the market's uncertainty.

Neuropace Inc Stock (NPCE) Year by Year Forecast

Neuropace Inc Stock (NPCE) Price Forecast for 2024

Our forecast for NPCE stock price in 2024 now indicates an average price target of $9.3527 with a high forecast of $18.15 and a low forecast of $0.5554. The average prediction reflects an increase of +34.19% from the last recorded price of $6.97.
Month Average Low High Change from today's price
November, 2024 $0.8526 $0.6426 $4.704 -87.77%
December, 2024 $1.6439 $0.5554 $2.9054 -76.41%

Neuropace Inc Stock (NPCE) Price Forecast for 2025

Neuropace Inc Stock (NPCE) is expected to reach an average price of $1.9717 in 2025, with a high prediction of $3.9337 and a low estimate of $0.00974. This indicates an -71.71% fall from the last recorded price of $6.97.
Month Average Low High Change from today's price
January, 2025 $2.1182 $0.8768 $3.4353 -69.61%
February, 2025 $2.2796 $1.5167 $3.2339 -67.29%
March, 2025 $0.061 $0.00974 $2.3324 -99.13%
April, 2025 $0.8948 $0.1366 $0.5652 -87.16%
May, 2025 $0.0934 $0.8963 $0.8363 -98.66%
June, 2025 $0.158 $0.292 $0.3651 -97.73%
July, 2025 $1.2278 $0.8692 $1.5107 -82.38%
August, 2025 $1.9564 $1.575 $1.8814 -71.93%
September, 2025 $2.655 $2.6036 $2.515 -61.91%
October, 2025 $3.9808 $2.6822 $3.6958 -42.89%
November, 2025 $3.8994 $3.9849 $3.8702 -44.05%
December, 2025 $2.4952 $2.7309 $3.9337 -64.20%

Neuropace Inc Stock (NPCE) Price Forecast for 2026

The predicted value for Neuropace Inc (NPCE) in 2026 is set at an average of $2.7035. Estimates vary from a peak of $4.7815 to a trough of $0.6255, indicating an -61.21% surge from the present price of $6.97.
Month Average Low High Change from today's price
January, 2026 $1.2488 $1.1066 $1.1623 -82.08%
February, 2026 $1.2724 $0.6352 $0.6609 -81.74%
March, 2026 $0.681 $1.171 $1.2539 -90.23%
April, 2026 $0.3068 $0.6968 $0.2825 -95.60%
May, 2026 $0.7554 $0.9083 $0.6811 -89.16%
June, 2026 $0.674 $1.1882 $0.8097 -90.33%
July, 2026 $0.9998 $0.9212 $0.8248 -85.66%
August, 2026 $0.5484 $0.8284 $1.3988 -92.13%
September, 2026 $3.6859 $0.6255 $4.5002 -47.12%
October, 2026 $1.0872 $1.0322 $4.7815 -84.40%
November, 2026 $2.2986 $0.9401 $2.6286 -67.02%
December, 2026 $4.0929 $1.6516 $4.6664 -41.28%

Neuropace Inc Stock (NPCE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Neuropace Inc (NPCE) is $7.1422, with a high forecast of $13.51 and a low forecast of $0.7746. This indicates an +2.47% increase from the last price of $6.97.
Month Average Low High Change from today's price
January, 2027 $5.5543 $2.6186 $5.5643 -20.31%
February, 2027 $9.8656 $4.7572 $10.39 +41.54%
March, 2027 $12.38 $8.7713 $13.51 +77.62%
April, 2027 $8.5913 $8.2384 $12.74 +23.26%
May, 2027 $8.9626 $7.5498 $11.24 +28.59%
June, 2027 $7.39 $7.05 $10.14 +6.03%
July, 2027 $10.72 $4.9867 $11.00 +53.84%
August, 2027 $2.8955 $2.7355 $11.62 -58.46%
September, 2027 $2.244 $1.834 $4.8926 -67.80%
October, 2027 $0.8932 $0.7746 $4.9997 -87.18%
November, 2027 $2.7104 $3.1875 $2.4518 -61.11%
December, 2027 $3.232 $2.8334 $2.2947 -53.63%

Neuropace Inc Stock (NPCE) Price Forecast for 2028

In 2028, Neuropace Inc (NPCE) is projected to reach an average price of $6.7087, with a high projection of $9.2866 and a low estimate of $4.1309. This indicates an -3.75% fall from the last price of $6.97.
Month Average Low High Change from today's price
January, 2028 $4.3292 $4.4506 $3.7306 -37.89%
February, 2028 $4.6264 $5.0135 $4.3521 -33.62%
March, 2028 $3.6779 $4.2579 $3.6307 -47.23%
April, 2028 $4.0152 $4.1309 $3.6952 -42.39%
May, 2028 $5.6967 $5.8267 $5.7781 -18.27%
June, 2028 $6.4439 $6.7353 $6.3089 -7.55%
July, 2028 $5.9812 $6.2312 $6.7225 -14.19%
August, 2028 $6.7727 $6.1141 $6.0927 -2.83%
September, 2028 $7.3199 $7.3199 $7.2814 +5.02%
October, 2028 $8.2971 $7.5542 $7.5878 +19.04%
November, 2028 $8.9187 $8.3244 $8.3587 +27.96%
December, 2028 $9.5459 $9.313 $9.2866 +36.96%

Neuropace Inc Stock (NPCE) Price Forecast for 2029

The 2029 price forecast for Neuropace Inc Stock (NPCE) is $5.4136 on average, with a high prediction of $9.4474 and a low estimate of $1.3797. This represents an -22.33% decrease from the previous price of $6.97.
Month Average Low High Change from today's price
January, 2029 $9.5374 $9.5553 $9.4474 +36.84%
February, 2029 $6.8347 $8.0747 $9.3667 -1.94%
March, 2029 $6.0719 $6.5433 $6.2176 -12.89%
April, 2029 $7.0591 $6.0205 $5.8291 +1.28%
May, 2029 $5.7906 $6.0806 $6.5877 -16.92%
June, 2029 $6.2279 $5.9536 $5.5649 -10.65%
July, 2029 $6.2751 $6.1266 $5.9551 -9.97%
August, 2029 $6.0366 $6.0623 $5.9894 -13.39%
September, 2029 $6.0038 $6.1109 $5.9838 -13.86%
October, 2029 $0.6354 $3.7253 $5.8681 -90.88%
November, 2029 $2.0326 $1.3797 $1.0326 -70.84%
December, 2029 $2.9398 $2.2712 $2.8798 -57.82%

Neuropace Inc Stock (NPCE) Price Forecast for 2030

Neuropace Inc Stock (NPCE) is expected to reach an average price of $4.442 in 2030, with a high forecast of $8.8697 and a low forecast of $0.0143. This signifies an -36.27% decrease from the last price of $6.97.
Month Average Low High Change from today's price
January, 2030 $1.0414 $1.7614 $3.0441 -85.06%
February, 2030 $1.1886 $1.0643 $0.7143 -82.95%
March, 2030 $1.4542 $0.0143 $1.7641 -79.14%
April, 2030 $5.237 $1.3856 $6.172 -24.86%
May, 2030 $6.9154 $4.0927 $8.8697 -0.78%
June, 2030 $4.7382 $3.4782 $7.6511 -32.02%
July, 2030 $4.3667 $2.9996 $6.70 -37.35%
August, 2030 $0.1915 $0.47 $5.2181 -97.25%
September, 2030 $0.9127 $0.3756 $5.1027 -86.91%
October, 2030 $2.6546 $2.4888 $2.9932 -61.91%
November, 2030 $1.8404 $3.9161 $3.4208 -73.59%
December, 2030 $9.0463 $7.1619 $6.8827 +29.79%
medical_devices ZBH
$107.95
price down icon 0.25%
medical_devices STE
$242.54
price up icon 1.46%
$67.04
price down icon 0.37%
medical_devices PHG
$32.72
price down icon 0.06%
medical_devices EW
$65.99
price down icon 0.89%
$93.85
price up icon 2.02%
Cap:     |  Volume (24h):